Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Lieber

Showing results (231-240 of 239) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 239 results.
Cancer Research|March 4, 1998
A molecular cytogenetic analysis of 7q31 in prostate cancerR B Jenkins, J Qian, H K Lee, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trialsD G Bostwick, H B Burke, T M Wheeler, et al.
The Journal of Urology|November 1, 1993
Similar levels of urological symptoms have similar impact on Scottish and American men--although Scots report less symptomsH A Guess, C G Chute, W M Garraway, et al.
Mayo Clinic Proceedings|November 11, 1992
A prospective randomized comparison of epidural infusion of fentanyl and intravenous administration of morphine by patient-controlled analgesia after radical retropubic prostatectomyP H Allaire, J M Messick, J E Oesterling, et al.
Cancer Research|May 1, 1985
Application of a human tumor colony-forming assay to new drug screeningR H Shoemaker, M K Wolpert-DeFilippes, D H Kern, et al.
Urology|August 1, 1996
Free, complexed, and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade, and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostateS E Lerner, S J Jacobsen, H Lilja, et al.
The Journal of Urology|October 12, 2000
A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinomaK C Halling, W King, I A Sokolova, et al.
Urology|April 10, 1999
Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years. The North American Finasteride Study GroupP B Hudson, R Boake, J Trachtenberg, et al.
The Journal of Urology|September 24, 1999
Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young menJ W Overstreet, V L Fuh, J Gould, et al.
Pageof 24

Showing results (231-240 of 239) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 239 results.
Cancer Research|March 4, 1998
A molecular cytogenetic analysis of 7q31 in prostate cancerR B Jenkins, J Qian, H K Lee, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1994
The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trialsD G Bostwick, H B Burke, T M Wheeler, et al.
The Journal of Urology|November 1, 1993
Similar levels of urological symptoms have similar impact on Scottish and American men--although Scots report less symptomsH A Guess, C G Chute, W M Garraway, et al.
Mayo Clinic Proceedings|November 11, 1992
A prospective randomized comparison of epidural infusion of fentanyl and intravenous administration of morphine by patient-controlled analgesia after radical retropubic prostatectomyP H Allaire, J M Messick, J E Oesterling, et al.
Cancer Research|May 1, 1985
Application of a human tumor colony-forming assay to new drug screeningR H Shoemaker, M K Wolpert-DeFilippes, D H Kern, et al.
Urology|August 1, 1996
Free, complexed, and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade, and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostateS E Lerner, S J Jacobsen, H Lilja, et al.
The Journal of Urology|October 12, 2000
A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinomaK C Halling, W King, I A Sokolova, et al.
Urology|April 10, 1999
Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years. The North American Finasteride Study GroupP B Hudson, R Boake, J Trachtenberg, et al.
The Journal of Urology|September 24, 1999
Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young menJ W Overstreet, V L Fuh, J Gould, et al.
Pageof 24